Combinostics at RSNA 2023
November 26 - 29 | Chicago, IL
Booth: 3971 in the AI Showcase
Will you be at the RSNA 2023 Annual Meeting? Visit booth 3971 in the AI Showcase, or contact our team to schedule a meeting to learn more about our cloud-based platform supporting our AI solutions (cMRI™, cDSI™ and cPET™), new amyloid and FDG PET quantification, industry-first Dementia Differential Analysis report, and new clinically focused cMRI reports for dementia, multiple sclerosis, traumatic brain injuries, and epilepsy.
Stop by and see the industry’s only neurological AI imaging and decision support solution spanning the entire patient care pathway for the early detection, diagnosis, and ongoing management of major neurological disorders
Using a combination of science and innovative AI technology, we aim to make a difference in the lives of patients with neurological disorders.
Our solutions put the focus on patients by providing objective, reliable insights for confident, evidence-based diagnostic and management decisions. Radiologists are better equipped to support referring clinicians and their patients with credible, validated imaging quantification and unique differential reporting for major neurological disorders.
Learn more at our presentation during RSNA.
Join us for a presentation given by our Vice President of European Sales Hans-Peter Huber.
Next level MRI quantification for Neurological Disorders
November 29 at 3:00 - 3:30pm CT in the deepc booth #4578
Schedule a meeting with our team.
Interested in a demo of our solutions and industry-leading diagnostic and clinically focused reports? Our team will be on the ground and ready to answer your questions.
Chief Executive Officer (CEO)
Vice President European Sales
US Sales Director
Clinical Applications Specialist
Go beyond neurological image quantification.
For conditions such as dementia, multiple sclerosis, traumatic brain injury, and epilepsy, our platform supports earlier disease detection; faster, more efficient, differential diagnostic support; longitudinal tracking and prediction of disease progression; and detection and management of side effects.
Our AI solutions include:
Dementia Differential Analysis report
The new Dementia Differential Analysis report is based on MRI data only, using our cDSI application’s proprietary machine learning method that measures the similarity of disease-specific imaging biomarker values from the patient to those from 2,000+ patients with a confirmed neurodegenerative disease.
It provides the probabilities of the following diagnoses for each patient:
- Cognitively normal
- Alzheimer’s disease
- Frontotemporal dementia
- Vascular dementia
Clinically focused cMRI reports
- Multiple sclerosis
- Traumatic brain injuries